Journal article
Faculty Opinions recommendation of Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.
- Mayr, Michael ORCID Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Switzerland
- Amico, Patrizia Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Switzerland
Published in:
- Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature. - Faculty Opinions Ltd. - 2017
- Language
-
- English
- Open access status
- closed
- Identifiers
- Persistent URL
- https://sonar.ch/global/documents/231977
Statistics
Document views: 20
File downloads: